{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:31:23Z","timestamp":1761561083858,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.jsat.2006.05.015","type":"journal-article","created":{"date-parts":[[2006,8,15]],"date-time":"2006-08-15T08:27:48Z","timestamp":1155630468000},"page":"411-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Substance abuse treatment and receipt of liver specialty care among persons coinfected with HIV\/HCV who have alcohol problems"],"prefix":"10.1016","volume":"31","author":[{"given":"Anita","family":"Palepu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie M.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Vidaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Alperen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Saitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Samet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2006.05.015_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0749-3797(18)30622-6","article-title":"Screening for depression in well older adults\u2014Evaluation of a short-form of the CES-D","volume":"10","author":"Andresen","year":"1994","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.jsat.2006.05.015_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1081\/ADA-200037544","article-title":"Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services","volume":"30","author":"Astone","year":"2004","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2006.05.015_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","article-title":"Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection","volume":"32","author":"Bica","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2006.05.015_bib4","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7326\/0003-4819-115-10-774","article-title":"Screening for alcohol-abuse using cage scores and likelihood ratios","volume":"115","author":"Buchsbaum","year":"1991","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2006.05.015_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa032653","article-title":"Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons","volume":"351","author":"Chung","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2006.05.015_bib6","doi-asserted-by":"crossref","first-page":"S362","DOI":"10.1086\/427454","article-title":"Integrating treatment for hepatitis C virus infection into an HIV clinic","volume":"40","author":"Clanon","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2006.05.015_bib7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.510270404","article-title":"Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis","volume":"27","author":"Corrao","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jsat.2006.05.015_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2893.2005.00685.x","article-title":"Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting","volume":"13","author":"Desmond","year":"2006","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.jsat.2006.05.015_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJM200107193450311","article-title":"Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?","volume":"345","author":"Edlin","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2006.05.015_bib10","doi-asserted-by":"crossref","first-page":"S346","DOI":"10.1086\/427451","article-title":"Use of community-based, directly observed therapy for HIV infection: Lessons learned for treatment of hepatitis C virus infection","volume":"40","author":"Flanigan","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2006.05.015_bib11","doi-asserted-by":"crossref","first-page":"S349","DOI":"10.1086\/427452","article-title":"Challenges in the treatment of patients co-infected with HIV and hepatitis C virus: Need for team care","volume":"40","author":"Fleming","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2006.05.015_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jsat.2006.05.015_bib13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/321909","article-title":"Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis","volume":"33","author":"Graham","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2006.05.015_bib14","first-page":"659","article-title":"Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens","volume":"160","author":"Hogg","year":"1999","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.jsat.2006.05.015_bib15","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1001\/jama.285.18.2355","article-title":"Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs","volume":"285","author":"Laine","year":"2001","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2006.05.015_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.jsat.2006.05.015_bib17","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.1086\/427450","article-title":"Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: Challenges and opportunities","volume":"40","author":"Litwin","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2006.05.015_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005053-198507000-00005","article-title":"New data from the addiction severity index: Reliability and validity in three centers","volume":"173","author":"McLellan","year":"1985","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2006.05.015_bib19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/321819","article-title":"Hepatitis C virus infection\u2014Related morbidity and mortality among patients with human immunodeficiency virus infection","volume":"33","author":"Monga","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2006.05.015_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1177\/002204260403400407","article-title":"Drug treatment programs as sites of opportunity for the delivery of hepatitis C prevention education: Client and staff perspectives","volume":"34","author":"Munoz-Plaza","year":"2004","journal-title":"Journal of Drug Issues"},{"key":"10.1016\/j.jsat.2006.05.015_bib21","first-page":"2082","article-title":"NIH consensus development conference statement: Management of hepatitis C","volume":"123","author":"National Institutes of Health","year":"2002","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1016\/j.jsat.2006.05.015_bib22","first-page":"S281","article-title":"Preparations for AIDS vaccine trials. An automated version of the risk assessment battery (RAB): Enhancing the assessment of risk behaviors","volume":"10","author":"Navaline","year":"1994","journal-title":"AIDS Research and Human Retroviruses"},{"key":"10.1016\/j.jsat.2006.05.015_bib23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators","volume":"338","author":"Palella","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2006.05.015_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.ALC.0000156101.84780.45","article-title":"Substance abuse treatment and hospitalization among a cohort of HIV-infected individuals with alcohol problems","volume":"29","author":"Palepu","year":"2005","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2006.05.015_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jsat.2004.09.002","article-title":"Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems","volume":"28","author":"Palepu","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2006.05.015_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/135965350400900503","article-title":"Initiating highly active antiretroviral therapy and continuity of HIV care: The impact of incarceration and prison release on adherence and HIV treatment outcomes","volume":"9","author":"Palepu","year":"2004","journal-title":"Antiviral Therapy"},{"key":"10.1016\/j.jsat.2006.05.015_bib27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00002030-200305020-00011","article-title":"Pegylated ifn-alpha 2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients","volume":"17","author":"Perez-Olmeda","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jsat.2006.05.015_bib28","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/hep.510270635","article-title":"Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C","volume":"27","author":"Pessione","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jsat.2006.05.015_bib29","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa030264","article-title":"Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection","volume":"349","author":"Robbins","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2006.05.015_bib30","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.1988.01800360017003","article-title":"The composite international diagnostic interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures","volume":"45","author":"Robins","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2006.05.015_bib31","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archinte.1995.00430150107011","article-title":"A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus","volume":"155","author":"Samet","year":"1995","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.jsat.2006.05.015_bib32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00002030-200204120-00001","article-title":"Care of patients with chronic hepatitis C and HIV co-infection: Recommendations from the HIV\u2013HCV international panel","volume":"16","author":"Soriano","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jsat.2006.05.015_bib33","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1086\/427445","article-title":"Factors associated with interest in initiating treatment for hepatitis C virus (HCV) infection among young HCV-infected injection drug users","volume":"40","author":"Strathdee","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2006.05.015_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/apc.2005.19.78","article-title":"Integrating hepatitis C services into existing HIV services: The experiences of a sample of US drug treatment units","volume":"19","author":"Strauss","year":"2005","journal-title":"AIDS Patient Care and STDs"},{"key":"10.1016\/j.jsat.2006.05.015_bib35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/jurban\/jth086","article-title":"The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units","volume":"81","author":"Strauss","year":"2004","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.jsat.2006.05.015_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.drugalcdep.2003.08.009","article-title":"A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States","volume":"73","author":"Strauss","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"1 Suppl","key":"10.1016\/j.jsat.2006.05.015_bib37","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2005.11.012","article-title":"Treatment algorithm for the management of hepatitis C in HIV-coinfected persons","volume":"44","author":"Sulkowski","year":"2006","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.jsat.2006.05.015_bib38","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1086\/313842","article-title":"Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus","volume":"30","author":"Sulkowski","year":"2000","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2006.05.015_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-138-3-200302040-00012","article-title":"Hepatitis C in the HIV-infected person","volume":"138","author":"Sulkowski","year":"2003","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2006.05.015_bib40","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.1086\/427447","article-title":"Treating hepatitis C virus infection in active substance users","volume":"40","author":"Sylvestre","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2006.05.015_bib41","doi-asserted-by":"crossref","first-page":"S355","DOI":"10.1086\/427453","article-title":"Delivering care to injection drug users co-infected with HIV and hepatitis C virus","volume":"40","author":"Taylor","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2006.05.015_bib42","first-page":"450","article-title":"The natural history of hepatitis C virus infection: Host, viral, and environmental factors","volume":"284","author":"Thomas","year":"2000","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2006.05.015_bib43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1353\/hpu.2004.0075","article-title":"Provision of on-site medical care to patients with hepatitis C in drug treatment units","volume":"15","author":"Vassilev","year":"2004","journal-title":"Journal of Health Care for the Poor and Underserved"},{"key":"10.1016\/j.jsat.2006.05.015_bib44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jsat.2004.12.004","article-title":"Knowledge of and interest in hepatitis C treatment at a methadone clinic","volume":"28","author":"Walley","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2006.05.015_bib45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Medical Care"},{"key":"10.1016\/j.jsat.2006.05.015_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547206001577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547206001577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:30:15Z","timestamp":1760038215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547206001577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0740547206001577"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2006.05.015","relation":{},"ISSN":["0740-5472"],"issn-type":[{"type":"print","value":"0740-5472"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance abuse treatment and receipt of liver specialty care among persons coinfected with HIV\/HCV who have alcohol problems","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2006.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}